About 2-ethyl-5-[1-ethyl-2-[[2-(3-fluorophenyl)pyrazol-3-yl]methyl]benzimidazol-5-yl]-1,3,4-oxadiazole
2-ethyl-5-[1-ethyl-2-[[2-(3-fluorophenyl)pyrazol-3-yl]methyl]benzimidazol-5-yl]-1,3,4-oxadiazole (PubChem CID 20811946) has the molecular formula C23H21FN6O
and a molecular weight of 416.46 g/mol. Its IUPAC name is 2-ethyl-5-[1-ethyl-2-[[2-(3-fluorophenyl)pyrazol-3-yl]methyl]benzimidazol-5-yl]-1,3,4-oxadiazole.
Molecular Properties
| Compound Name | 2-ethyl-5-[1-ethyl-2-[[2-(3-fluorophenyl)pyrazol-3-yl]methyl]benzimidazol-5-yl]-1,3,4-oxadiazole |
| PubChem CID | 20811946 |
| Molecular Formula | C23H21FN6O |
| Molecular Weight | 416.46 g/mol |
| Exact Mass | 416.18 |
| IUPAC Name | 2-ethyl-5-[1-ethyl-2-[[2-(3-fluorophenyl)pyrazol-3-yl]methyl]benzimidazol-5-yl]-1,3,4-oxadiazole |
| SMILES | CCc1nnc(-c2ccc3c(c2)nc(Cc2ccnn2-c2cccc(F)c2)n3CC)o1 |
| InChI | InChI=1S/C23H21FN6O/c1-3-22-27-28-23(31-22)15-8-9-20-19(12-15)26-21(29(20)4-2)14-18-10-11-25-30(18)17-7-5-6-16(24)13-17/h5-13H,3-4,14H2,1-2H3 |
| InChIKey | MSEABBGDEHGHHY-UHFFFAOYSA-N |
| XLogP | 4.58 |
| TPSA | 74.56 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
| MW ≤ 500 | 416.46 |
| LogP ≤ 5 | 4.58 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 7 |
Analyze 2-ethyl-5-[1-ethyl-2-[[2-(3-fluorophenyl)pyrazol-3-yl]methyl]benzimidazol-5-yl]-1,3,4-oxadiazole with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 2-ethyl-5-[1-ethyl-2-[[2-(3-fluorophenyl)pyrazol-3-yl]methyl]benzimidazol-5-yl]-1,3,4-oxadiazole?
The IUPAC name of 2-ethyl-5-[1-ethyl-2-[[2-(3-fluorophenyl)pyrazol-3-yl]methyl]benzimidazol-5-yl]-1,3,4-oxadiazole (CID 20811946) is 2-ethyl-5-[1-ethyl-2-[[2-(3-fluorophenyl)pyrazol-3-yl]methyl]benzimidazol-5-yl]-1,3,4-oxadiazole.
What is the SMILES notation for 2-ethyl-5-[1-ethyl-2-[[2-(3-fluorophenyl)pyrazol-3-yl]methyl]benzimidazol-5-yl]-1,3,4-oxadiazole?
The canonical SMILES for 2-ethyl-5-[1-ethyl-2-[[2-(3-fluorophenyl)pyrazol-3-yl]methyl]benzimidazol-5-yl]-1,3,4-oxadiazole is CCc1nnc(-c2ccc3c(c2)nc(Cc2ccnn2-c2cccc(F)c2)n3CC)o1.
What is the InChIKey of 2-ethyl-5-[1-ethyl-2-[[2-(3-fluorophenyl)pyrazol-3-yl]methyl]benzimidazol-5-yl]-1,3,4-oxadiazole?
The InChIKey is MSEABBGDEHGHHY-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H21FN6O/c1-3-22-27-28-23(31-22)15-8-9-20-19(12-15)26-21(29(20)4-2)14-18-10-11-25-30(18)17-7-5-6-16(24)13-17/h5-13H,3-4,14H2,1-2H3.
What are the key properties of 2-ethyl-5-[1-ethyl-2-[[2-(3-fluorophenyl)pyrazol-3-yl]methyl]benzimidazol-5-yl]-1,3,4-oxadiazole?
2-ethyl-5-[1-ethyl-2-[[2-(3-fluorophenyl)pyrazol-3-yl]methyl]benzimidazol-5-yl]-1,3,4-oxadiazole has a molecular weight of 416.46 g/mol, XLogP of 4.58, 6 rotatable bonds, 0 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 2-ethyl-5-[1-ethyl-2-[[2-(3-fluorophenyl)pyrazol-3-yl]methyl]benzimidazol-5-yl]-1,3,4-oxadiazole is sourced from PubChem (CID 20811946), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).